Assertio Holdings Inc (ASRT) reports robust financial growth in Q3 2025, driven by strong Rolvidon sales, despite facing competitive pressures and strategic shifts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback